Near fatal case of mirvetuximab soravtansine-gynx induced interstitial lung disease and a review of the primary literature

• Joshua Clark,
• Andrew Blake,
• Scott Vasher,
• Richard C. Boucher,
• Alexis R. Jones,
• Hee Jae Choi,
• Benjamin B. Albright

Affiliations

Joshua Clark

University of North Carolina – Chapel Hill, Division of Pulmonary and Critical Care Medicine, USA; Corresponding author at: University of North Carolina-Chapel Hill, Division of Pulmonary and Critical Care Medicine, CB #7020, 130 Mason Farm Rd, 4th Floor Bioinformatics, Chapel Hill, NC 27599-7020, USA.

Andrew Blake

University of North Carolina – Chapel Hill, Division of Pulmonary and Critical Care Medicine, USA

Scott Vasher

University of North Carolina – Chapel Hill, Division of Pulmonary and Critical Care Medicine, USA

Richard C. Boucher

University of North Carolina – Chapel Hill, Division of Pulmonary and Critical Care Medicine, USA

Alexis R. Jones

University of North Carolina – Chapel Hill, Division of Gynecology Oncology, USA

Hee Jae Choi

University of North Carolina – Chapel Hill, Division of Pulmonary and Critical Care Medicine, USA

Benjamin B. Albright

University of North Carolina – Chapel Hill, Division of Gynecology Oncology, USA